ConductScience.org, home

Paper35580929

CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy.

Xiao M and 24 others. J Immunother Cancer, 2022. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy. Papers, record 35580929. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35580929

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy.
PubMed
Journal
J Immunother Cancer
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
3.3
iCite
Revised in PubMed
2022-10-25
PubMed

Authors25

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Xiao MMinglu
2Xie LLuoyingzi
3Cao GGuoshuai
4Lei SShun
5Wang PPengcheng
6Wei ZZhengping
7Luo YYuan
8Fang JJingyi
9Yang XXingxing
10Huang QQizhao
11Xu LLifan
12Guo JJunyi
13Wen SShuqiong
14Wang ZZhiming
15Wu QQing
16Tang JJianfang
17Wang LLisha
18Chen XXiangyu
19Chen CCheng
20Zhang YYanyan

Source PubMed

See all 25 authorsDownload CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Colorectal NeoplasmsMajor topic
MelanomaMajor topic
Animals
B7-H1 Antigen
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Epitopes, T-Lymphocyte
Glycoproteins
Humans
Immune Checkpoint Inhibitors
Immunotherapy
Mice
Ovalbumin
Programmed Cell Death 1 Receptor
Receptors, Antigen, T-Cell
Tumor Microenvironment
Vaccination

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in36283738Correction: CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy.https://conductscience.org/library/papers/36283738

Source PubMed

Download CSV of comments and corrections

References59

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120940398CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes.Cancer Res2010https://conductscience.org/library/papers/20940398PubMed
29624004Help for cytotoxic-T-cell responses is mediated by CD40 signalling.Nature1998https://conductscience.org/library/papers/9624004PubMed
320525992Improved survival with ipilimumab in patients with metastatic melanoma.N Engl J Med2010https://conductscience.org/library/papers/20525992PubMed
431810882Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection.Immunity2019https://conductscience.org/library/papers/31810882PubMed
530635236Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1-CD8+ Tumor-Infiltrating T Cells.Immunity2019https://conductscience.org/library/papers/30635236PubMed
632477338Bcl6 Preserves the Suppressive Function of Regulatory T Cells During Tumorigenesis.Front Immunol2020https://conductscience.org/library/papers/32477338PubMed
726412456Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.N Engl J Med2015https://conductscience.org/library/papers/26412456PubMed
82137372Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response.Cell1990https://conductscience.org/library/papers/2137372PubMed
97525709Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.J Immunol1994https://conductscience.org/library/papers/7525709PubMed
1029567705Cancer immunotherapy using checkpoint blockade.Science2018https://conductscience.org/library/papers/29567705PubMed
1130057419CD4+ T cell help in cancer immunology and immunotherapy.Nat Rev Immunol2018https://conductscience.org/library/papers/30057419PubMed
1229126798CD4+ T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness.Immunity2017https://conductscience.org/library/papers/29126798PubMed
1325858804Immune checkpoint blockade: a common denominator approach to cancer therapy.Cancer Cell2015https://conductscience.org/library/papers/25858804PubMed
1418770580Influenza: propagation, quantification, and storage.Curr Protoc Microbiol2006https://conductscience.org/library/papers/18770580PubMed
1521739672T cell exhaustion.Nat Immunol2011https://conductscience.org/library/papers/21739672PubMed
1626406148Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.N Engl J Med2015https://conductscience.org/library/papers/26406148PubMed
1727192570Targeting T Cell Co-receptors for Cancer Therapy.Immunity2016https://conductscience.org/library/papers/27192570PubMed
1830676822CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer.Annu Rev Immunol2019https://conductscience.org/library/papers/30676822PubMed
1922790179Cross-presentation by dendritic cells.Nat Rev Immunol2012https://conductscience.org/library/papers/22790179PubMed
209740780Transfectant influenza A viruses are effective recombinant immunogens in the treatment of experimental cancer.Virology1998https://conductscience.org/library/papers/9740780PubMed

See all 59 referencesDownload CSV of references

Cited by41

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
42515567Synthetic Biology Strategies for the Development of Live Attenuated Influenza Viruses: Recent Advances and Applications.Viruses2026https://conductscience.org/library/papers/42515567PubMed
42351104Virus-like particles in cancer immunotherapy: bridging human and veterinary medicine through one health.J Nanobiotechnology2026https://conductscience.org/library/papers/42351104PubMed
42258951An immunogenomic classification of solid tumours reveals subtype-specific therapeutic vulnerabilities for immunotherapy.EBioMedicine2026https://conductscience.org/library/papers/42258951PubMed
42011487Vaccination with cationic liposome-encapsulated CD4 and CD8 T cell neoepitopes induces superior tumor control.Mater Today Bio2026https://conductscience.org/library/papers/42011487PubMed
41977251Immune Escape in Renal Cell Carcinoma: Latest Research and Treatment Strategies.Int J Mol Sci2026https://conductscience.org/library/papers/41977251PubMed
41969464Prognostic value of systemic inflammation indices in patients with metastatic colorectal cancer treated with TAS-102: a single-center retrospective real-world study.Transl Cancer Res2026https://conductscience.org/library/papers/41969464PubMed
41739190Heterologous prime-boost immunization of AAV-based neoantigen cancer vaccine induces anti-tumor immunity to inhibit tumor growth and relapse.Cancer Immunol Immunother2026https://conductscience.org/library/papers/41739190PubMed
41608565The novel B-cell epitope peptide vaccine, MAX449, exhibits significant anti-tumor efficacy and enhances the therapeutic effects of PD-1 antibodies on tumors by modulating the activity of PMN-MDSCs.Theranostics2026https://conductscience.org/library/papers/41608565PubMed
41588956Tumor-embedded Immunity and TRM Cell Functions in Cancer.Mini Rev Med Chem2026https://conductscience.org/library/papers/41588956PubMed
41425703Immune Checkpoint Inhibitors Combined with Oncolytic Virotherapy: Synergy, Heterogeneity, and Safety in Cancer Treatment.Oncol Res2025https://conductscience.org/library/papers/41425703PubMed
41408237PD-1/PD-L1 pathway relieves incision induced acute postoperative pain via inhibiting the neuroinflammation in dorsal root ganglion of rats.Sci Rep2025https://conductscience.org/library/papers/41408237PubMed
41348109Chimeric MHC class I- and II-restricted non-self epitopes broaden antitumor T cell reactions.J Exp Med2026https://conductscience.org/library/papers/41348109PubMed
41137391DCC-2036 induces repolarization of TAMs to M1 type and enhances CD8+ T cell immunity in TNBC.Mol Ther2026https://conductscience.org/library/papers/41137391PubMed
41079643Immune Surveillance and Immune Escape in Cancer: Mechanisms and Immunotherapy.MedComm (2020)2025https://conductscience.org/library/papers/41079643PubMed
40860882Nanoengineered-based delivery systems to modulate CD4+ T cell responses in cancer: emerging paradigms in cancer immunotherapy.Front Pharmacol2025https://conductscience.org/library/papers/40860882PubMed
40692748Enhanced efficacy of immune checkpoint inhibitors with OK-432 in malignant pleural mesothelioma: A case report.Mol Clin Oncol2025https://conductscience.org/library/papers/40692748PubMed
40615377Tislelizumab (anti-PD-1) plus chemotherapy as neoadjuvant therapy for patients with stage IB3/IIA2 cervical cancer (NATIC): a prospective, single-arm, phase II study.Signal Transduct Target Ther2025https://conductscience.org/library/papers/40615377PubMed
40585991NGR-modified nanovesicles target ALKBH5 to inhibit ovarian cancer growth and metastasis.Theranostics2025https://conductscience.org/library/papers/40585991PubMed
40573908Synergistic Antitumor Effects of Caerin Peptides and Dendritic Cell Vaccines in a 4T-1 Murine Breast Cancer Model.Vaccines (Basel)2025https://conductscience.org/library/papers/40573908PubMed
40539075Construction and evaluation of a Salmonella minicell-based dendritic cell-targeted multi-epitope vaccine against Helicobacter pylori.Front Immunol2025https://conductscience.org/library/papers/40539075PubMed

See all 41 cited byDownload CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35580929

GET https://conductscience.org/api/papers/v1/35580929/authors?page=2